Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low-and middle-income countries: Systematic review and meta-analysis

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 4, 2011, Pages

  Metcalfe, John Z ^a,b   Everett, Charles K ^a   Steingart, Karen R ^b   Cattamanchi, Adithya ^a,b   Huang, Laurence ^a,c   Hopewell, Philip C ^a,b   Pai, Madhukar ^d  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BULGARIA; CHINA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; IRAN; LUNG TUBERCULOSIS; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SENSITIVITY AND SPECIFICITY; SOCIOECONOMICS; SOUTH AFRICA; SYSTEMATIC REVIEW; TANZANIA; TUBERCULIN TEST; TURKEY (REPUBLIC); UGANDA; ZAMBIA;

ADULT; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA RELEASE TESTS; PREDICTIVE VALUE OF TESTS; SOCIOECONOMIC FACTORS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 79959290240     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir410     Document Type: Review

References (59)

1. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn 2006; 6:413-22. (Pubitemid 44174345)
2. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146:340-54. (Pubitemid 351650594)
3. Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004; 4:761-76.
4. Pai M, Zwerling A, Menzies D. Systematic review: T cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149:177-84.
5. Mazurek G, Jereb J, Vernon A, LoBue P, Goldberg S. Updated guidelines for using interferon-gamma release assays to detect Mycobacterium tuberculosis infection, United States. MMWR. In press.
6. CTC. Canada communicable disease report: updated recommendations on interferon gamma release assays for latent tuberculosis infection, 2008.
7. NHS. Health Protection Agency position statement on the use of interferon gamma release assay (IGRA) tests for tuberculosis (TB). HPA Tuberculosis Programme Board, 2008.
8. Lange C, Pai M, Drobniewski F, Migliori GB. Interferon-gamma release assays for the diagnosis of active tuberculosis: sensible or silly? Eur Respir J 2009; 33:1250-3.
9. Menzies D. Using tests for latent tuberculous infection to diagnose active tuberculosis: can we eat our cake and have it too? Ann Intern Med 2008; 148:398-9. (Pubitemid 351665470)
10. Pai M, Menzies D. Interferon-gamma release assays: what is their role in the diagnosis of active tuberculosis? Clin Infect Dis 2007; 44: 74-7. (Pubitemid 44968988)
11. Sester M, Sotgiu G, Lange C, et al. Interferon-{gamma} release assays for the diagnosis of active tuberculosis: a systematic review and metaanalysis. Eur Respir J.
12. Dheda K, van Zyl Smit R, Badri M, Pai M. T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med 2009; 15:188-200.
13. Denkinger CM, Dheda K, Pai M. Guidelines on interferon-c release assays for tuberculosis infection: concordance, discordance or confusion? Clin Microbiol Infect 2011; 6:806-14.
14. Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 2010; 137:952-68.
15. Jiang W, Shao L, Zhang Y, et al. High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area. BMC Immunol 2009; 10:31.
16. Kanunfre KA, Leite OH, Lopes MI, Litvoc M, Ferreira AW. Enhancement of diagnostic efficiency by a gamma interferon release assay for pulmonary tuberculosis. Clin Vaccine Immunol 2008; 15:1028-30. (Pubitemid 351967000)
17. Soysal A, Torun T, Efe S, Gencer H, Tahaoglu K, Bakir M. Evaluation of cut-off values of interferon-gamma-based assays in the diagnosis of M. tuberculosis infection. Int J Tuberc Lung Dis 2008; 12: 50-6.
18. Deville WL, Buntinx F, Bouter LM, et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2002; 2:9.
19. Gatsonis C, Paliwal P. Meta-analysis of diagnostic and screening test accuracy evaluations: methodologic primer. AJR Am J Roentgenol 2006; 187:271-81. (Pubitemid 44148267)
20. Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM. Systematic reviews of diagnostic test accuracy. Ann Intern Med 2008; 149:889-97.
21. Pai M, McCulloch M, Enanoria W, Colford JM Jr. Systematic reviews of diagnostic test evaluations: what's behind the scenes? ACP J Club 2004; 141:A11-3.
22. World Bank List of Economies. http://siteresources.worldbank.org/ DATASTATISTICS/Resources/CLASS.XLSApril 2010. Accessed 1 June 2010.
23. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3:25.
24. Fontela PS, Pant Pai N, Schiller I, Dendukuri N, Ramsay A, Pai M. Quality and reporting of diagnostic accuracy studies in TB, HIV and malaria: evaluation using QUADAS and STARD standards. PLoS One 2009; 4:e7753.
25. Pai M, Minion J, Steingart K, Ramsay A. New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Curr Opin Pulm Med 2010; 16:271-84.
26. Schunemann HJ, Oxman AD, Brozek J, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 2008; 336:1106-10. (Pubitemid 351731739)
27. Rutjes AW, Reitsma JB, Di Nisio M, Smidt N, van Rijn JC, Bossuyt PM. Evidence of bias and variation in diagnostic accuracy studies. CMAJ 2006; 174:469-76.
28. Van Deun A. What is the role of mycobacterial culture in diagnosis and case definition? In: Frieden T, ed. Toman's tuberculosis: case detection, treatment, and monitoring-questions and answers, 2nd ed. World Health Organization, 2004; 35-43.
29. Lijmer JG, Bossuyt PM, Heisterkamp SH. Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med 2002; 21: 1525-37. (Pubitemid 34746061)
30. Rutter CM, Gatsonis CA. A hierarchical regression approach to metaanalysis of diagnostic test accuracy evaluations. Stat Med 2001; 20: 2865-84. (Pubitemid 32923212)
31. Harbord R, Whiting P. Metandi: meta-analysis of diagnostic accuracy using hierarchical logistic regression. Stata J 2009; 9:211-29.
32. Harbord RM, Deeks JJ, Egger M, Whiting P, Sterne JA. A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics 2007; 8:239-51. (Pubitemid 46569586)
33. Aabye MG, Ravn P, PrayGod G, et al. The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS One 2009; 4: e4220.
34. Cattamanchi A, Smith R, Steingart KR, et al. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr 2011; 56:230-8.
35. Chegou NN, Black GF, Kidd M, van Helden PD, Walzl G. Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm Med 2009; 9:21.
36. Chen X, Yang Q, Zhang M, et al. Diagnosis of active tuberculosis in China using an in-house gamma interferon enzyme-linked immunospot assay. Clin Vaccine Immunol 2009; 16:879-84.
37. Dheda K, van Zyl-Smit RN, Meldau R, et al. Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis. Thorax 2009; 64:847-53.
38. Kabeer BSA, Sikhamani R, Swaminathan S, Perumal V, Paramasivam P, Raja A. Role of interferon gamma release assay in active TB diagnosis among HIV infected individuals. PLoS One 2009; 4:e5718.
39. Katiyar SK, Sampath A, Bihari S, Mamtani M, Kulkarni H. Use of the QuantiFERON-TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2008; 12: 1146-52.
40. Leidl L, Mayanja-Kizza H, Sotgiu G, et al. Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD41 T cells in HIV-infection. Eur Respir J 2010; 35:619-26.
41. Markova R, Todorova Y, Drenska R, Elenkov I, Yankova M, Stefanova D. Usefulness of interferon-gamma release assays in the diagnosis of tuberculosis infection in HIV-infected patients in Bulgaria. Biotechnology & Biotechnological Equipment 2009; 23:1103-8.
42. Oni T, Patel J, Gideon HP, et al. Enhanced diagnosis of HIV-1 associated tuberculosis by relating T-SPOT.TB and CD4 counts. Eur Respir J 2010; 36:594-600.
43. Ozekinci T, Ozbek E, Celik Y. Comparison of tuberculin skin test and a specific T cell-based test, T-Spot.TB, for the diagnosis of latent tuberculosis infection. J Int Med Res 2007; 35:696-703. (Pubitemid 47570491)
44. Pai M, Joshi R, Bandyopadhyay M, et al. Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T cell responses during anti-tuberculosis treatment. Infection 2007; 35:98-103. (Pubitemid 46536774)
45. Raby E, Moyo M, Devendra A, et al. The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis. PLoS One 2008; 3:e2489.
46. Huang S, Lu S, Zhu Z, et al. Enzyme-linked immunospot assay combined with serum latex agglutination test for diagnosis of pulmonary tuberculosis and concomitant pulmonary cryptococcosis. Chin J Infect Chemother 2009; 9:252-5.
47. Tahereh K, Alireza N, Massoud S, Amina K. A validity study of the QuantiFERON-TB Gold (QFT-TB) method for the diagnosis of pulmonary tuberculosis in a high risk population. Swiss Med Wkly 2010; 140:95-6.
48. Tsiouris SJ, Coetzee D, Toro PL, Austin J, Stein Z, El-Sadr W. Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J Clin Microbiol 2006; 44:2844-50. (Pubitemid 44228579)
49. Veldsman C, Kock MM, Rossouw T, et al. QuantiFERON-TB GOLD ELISA assay for the detection of Mycobacterium tuberculosis-specific antigens in blood specimens of HIV-positive patients in a high-burden country. FEMS Immunol Med Microbiol 2009; 57:269-73.
50. WHO. Global tuberculosis control 2010. Geneva: World Health Organization, 2010.
51. Leeflang MM, Bossuyt PM, Irwig L. Diagnostic test accuracy may vary with prevalence: implications for evidence-based diagnosis. J Clin Epidemiol 2009; 62:5-12.
52. Brenner H, Gefeller O. Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence. Stat Med 1997; 16:981-91. (Pubitemid 27198986)
53. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336:924-6. (Pubitemid 351632017)
54. Andersen P, Doherty TM, Pai M, Weldingh K. The prognosis of latent tuberculosis: can disease be predicted? Trends Mol Med 2007; 13: 175-82. (Pubitemid 46687128)
55. Barry CE 3rd, Boshoff HI, Dartois V, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 2009; 7:845-55.
56. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007; 115:928-35. (Pubitemid 46294733)
57. Metcalfe JZ, Cattamanchi A, Vittinghoff E, et al. Evaluation of quantitative IFN-gamma response for risk stratification of active tuberculosis suspects. Am J Respir Crit Care Med 2010; 181:87-93.
58. Rangaka MX, Gideon HP, Wilkinson KA, et al. No discriminatory value of interferon release added to smear negative HIV-tuberculosis algorithms. Eur Respir J 2011; doi:10.1183.09031936.00058911.
59. WHO. Strategic and Technical Advisory Group for Tuberculosis (STAG-TB): report of the tenth meeting. Geneva: World Health Organization, 2010. http://www.who.int/tb/advisory-bodies/stag-tb-report-2010.pdf. Accessed 1 December 2010.